Skip Navigation

European Heart Journal 2003 24(2):172-181; doi:10.1016/S0195-668X(02)00325-1
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Newby, L.K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newby, L.K
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Predictors of 90-day outcome in patients stabilized after acute coronary syndromes

L.K Newbya,*, M.V Bhapkara, H.D Whiteb, E.J Topolc, F.C Doughertyd, R.A Harringtona, M.C Smithd, L.F Asarchd and R.M Califfa for the SYMPHONY and 2nd SYMPHONY Investigators

a Duke Clinical Research Institute, Durham, NC, USA
b Green Lane Hospital, Auckland, New Zealand
c Cleveland Clinic Foundation, Cleveland, OH, USA
d F. Hoffmann-La Roche, Ltd, Basel, Switzerland

Received April 16, 2002; accepted April 17, 2002 * Correspondence: L. Kristin Newby, MD, Duke Clinical Research Institute, P.O. Box 17969, Durham, NC, 27715-7969, U.S.A.

Aims We investigated predictors of 90-day risk among patients surviving the early period after an acute coronary syndrome (ACS).

Methods and Results The study population included 15 904 stabilized ST-segment elevation or non-ST-segment elevation ACS patients randomized in SYMPHONY and 2nd SYMPHONY. We developed risk models for death, death or myocardial infarction (MI), and death, MI, or severe recurrent ischaemia (SRI) using Cox proportional-hazards techniques. Demographic, history, and pre-randomization clinical and medication variables were tested. Validation techniques included development of individual trial models, backward elimination and bootstrapping. Of 118 variables, 17 independently predicted mortality. The strongest associations included greater age ({chi}2=31.1), higher randomization heart rate ({chi}2=27.4), and heart failure (HF) variables (HF between qualifying event and randomization, {chi}2=21.8; history of HF, {chi}2=12.2). Higher creatinine clearance ({chi}2=17.7) and percutaneous coronary intervention between qualifying event and randomization ({chi}2=11.1) most strongly predicted lower risk. Similar characteristics entered the double and triple composite models, but HF variables and age less strongly predicted these end-points.

Conclusions In patients stabilized after ACS, those at highest risk over the next 90 days can be identified. Typical clinical markers are better at identifying risk of death than non-fatal MI or SRI. Novel risk markers are needed for these outcomes.

Key Words: Acute coronary syndromes • risk models • outcomes • risk stratification


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BMJHome page
K. A A Fox, O. H Dabbous, R. J Goldberg, K. S Pieper, K. A Eagle, F. Van de Werf, A. Avezum, S. G Goodman, M. D Flather, F. A Anderson Jr, et al.
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
BMJ, November 25, 2006; 333(7578): 1091 - 1091.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
K. P. Alexander, L. K. Newby, M. V. Bhapkar, H. D. White, J. S. Hochman, M. E. Pfisterer, D. J. Moliterno, E. D. Peterson, F. Van de Werf, P. W. Armstrong, et al.
International variation in invasive care of the elderly with acute coronary syndromes
Eur. Heart J., July 1, 2006; 27(13): 1558 - 1564.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Rosengren, L. Wallentin, M. Simoons, A. K Gitt, S. Behar, A. Battler, and D. Hasdai
Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey
Eur. Heart J., April 1, 2006; 27(7): 789 - 795.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. N. Reddan, L. Szczech, M. V. Bhapkar, D. J. Moliterno, R. M. Califf, E. M. Ohman, P. B. Berger, J. S. Hochman, F. Van de Werf, R. A. Harrington, et al.
Renal function, concomitant medication use and outcomes following acute coronary syndromes
Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2105 - 2112.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. N. Foley, A. M. Murray, S. Li, C. A. Herzog, A. M. McBean, P. W. Eggers, and A. J. Collins
Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999
J. Am. Soc. Nephrol., February 1, 2005; 16(2): 489 - 495.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.